VICENISTATIN
Compound with spectra: 2 NMR
| SpectraBase Compound ID | HEG8sScUh44 |
|---|---|
| InChI | InChI=1S/C30H48N2O4/c1-21-12-8-7-9-13-23(3)20-32-28(34)15-11-10-14-24(4)27(17-16-22(2)18-21)36-29-19-26(33)30(31-6)25(5)35-29/h7-8,10-12,14-16,23-27,29-31,33H,9,13,17-20H2,1-6H3,(H,32,34)/b8-7+,14-10+,15-11+,21-12+,22-16+/t23-,24-,25+,26-,27-,29-,30+/m0/s1 |
| InChIKey | FINGADBUNZWVLV-KVAOKYIVSA-N |
| Mol Weight | 500.7 g/mol |
| Molecular Formula | C30H48N2O4 |
| Exact Mass | 500.361408 g/mol |
| Enantiomer InChIKey | FINGADBUNZWVLV-LANBOHPOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
3'-EPI-18-DESMETHYLVICENISATIN
18-DESMETHYLVICENISTATIN
Methyl-4,6-dideoxy-4-(2-deoxy-l-glycero-tetronamido)-2-O-methyl.alpha.d-mannopyranoside
Methyl-4,6-dideoxy-4-(2-hydroxy-propionamido)-2-O-methyl.alpha.d-mannopyranoside
ICARISIDE C2
METHYL-2-O-(2-DEOXY-ALPHA-L-RHAMNOPYRANOSYL)-ALPHA-L-RHAMNOPYRANOSIDE
DQMDYCOSANZACI-AIUIHKPUSA-N
(2S,3R,4S,5S,6R)-2-[1-methyl-1-(4-methyl-1-cyclohex-3-enyl)ethoxy]-6-methylol-tetrahydropyran-3,4,5-triol
LOBETYOLIN;9-O-BETA-D-GLUCOPYRANOSYL-2,10-TETRADECADIEN-4,6-DIYNE-8,14-DIOL
FEUOJOODDPASMF-CUCDKWAMSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Involvement of Glutamate Mutase in the Biosynthesis of the Unique Starter Unit of the Macrolactam Polyketide Antibiotic Vicenistatin | The Journal of Antibiotics | 2005 |
| Isolation and Structure Elucidation of Vicenistatin M, and Importance of the Vicenisamine Aminosugar for Exerting Cytotoxicity of Vicenistatin. | The Journal of Antibiotics | 2001 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.